Edges in Network
| Network | GSE12093_top500tf - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MAX |
| Upstream (Parents) |
|---|
| (<<) ZFP36L2 → MAX |
| (<<) ENO1 → MAX |
| (<<) PHOX2B → MAX |
| (<<) POU4F2 → MAX |
| (<<) STAT3 → MAX |
| (<<) CNOT8 → MAX |
| (<<) GATAD1 → MAX |
| Downstream (Children) |
|---|
| MAX → PGR (>>) |
| MAX → EHF (>>) |
| MAX → TP53 (>>) |
| MAX → ESR1 (>>) |
| MAX → ZEB1 (>>) |
| MAX → PBX1 (>>) |
| MAX → KLF6 (>>) |
| MAX → ARNTL (>>) |
| MAX → CITED2 (>>) |
| MAX → KLF4 (>>) |
| MAX → STAT1 (>>) |
| MAX → RUNX1 (>>) |
| MAX → FOXJ1 (>>) |
| MAX → ONECUT1 (>>) |
| MAX → NR5A1 (>>) |
| MAX → NFYC (>>) |
| MAX → SMAD3 (>>) |
| MAX → HNF1B (>>) |
| MAX → MYC (>>) |
| MAX → NR1H4 (>>) |
| MAX → GABPA (>>) |
| MAX → HOXA11 (>>) |
| MAX → RXRB (>>) |
| MAX → NR2F6 (>>) |
| MAX → ATF6B (>>) |
| MAX → RXRA (>>) |
| MAX → TSC22D3 (>>) |
| MAX → SREBF1 (>>) |
| MAX → CDKN2A (>>) |
| MAX → MBD1 (>>) |
| MAX → ZNF500 (>>) |
| MAX → HOXD11 (>>) |
| MAX → TAF12 (>>) |
| MAX → TRIM25 (>>) |
| MAX → TAL1 (>>) |
| MAX → CBFB (>>) |
| MAX → BTG2 (>>) |
| MAX → RXRG (>>) |
| MAX → GTF2I (>>) |
